Bone marrow transplantation in children with severe aplastic anemia using a conditioning regimen containing 3 Gy of total body irradiation, cyclophosphamide with or without antithymocyte globulin

Pediatric Transplantation

Volumn 11, Issue 2, 2007, Pages 180-186

  Inagaki, Jiro ^a   Nagatoshi, Yoshihisa ^a   Kawano, Yoshifumi ^a,b   Saito, Yusuke ^a   Takahashi, Daijiro ^a   Nagayama, Jun ^a   Shinkoda, Yuichi ^a   Hirata, Hideki ^a   Okamura, Jun ^a  

^a National Hospital Organization   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

3 Gy total body irradiation; Children; Engraftment; Late complication; Severe aplastic anemia

Indexed keywords

AMPHOTERICIN B; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; VORICONAZOLE; ZETBULIN;

ADD ON THERAPY; ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CATARACT; CHILD; CHIMERA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GONAD DYSFUNCTION; GRAFT REJECTION; HEMORRHAGIC CYSTITIS; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG ASPERGILLOSIS; LUNG DISEASE; LYMPHOPROLIFERATIVE DISEASE; MALE; MALIGNANT NEOPLASTIC DISEASE; MENSTRUATION; MUCOSA INFLAMMATION; ORGAN DONOR; RADIATION DOSE; RADIATION EXPOSURE; STOMATITIS; SURVIVAL RATE; THYROID DISEASE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ANEMIA, APLASTIC; ANTILYMPHOCYTE SERUM; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; FEMALE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; RADIOTHERAPY DOSAGE; TRANSPLANTATION CONDITIONING;

EID: 33846648810     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2006.00640.x     Document Type: Article

References (46)

1. KAHL C, LEISENRING W, DEEG HJ, et al. Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: A long-term follow-up. Br J Haematol 2005: 130: 747-751.
2. KOJIMA S, HORIBE K, INABA J, et al. Long-term outcome of acquired aplastic anemia in children; comparison between immunosuppressive therapy and bone marrow transplantation. Br J Haematol 2000: 111: 321-328.
3. KOJIMA S, KOBAYASHI R, YABE H, et al. High incidence of graft rejection in children with severe aplastic anemia preconditioned with cyclophosphamide and antithymocyte globulin regimen. Blood 2001: 98 (Suppl.): 376b.
4. DAVIES SM, WAGNER JE, DEFOR T, et al. Unrelated donor bone marrow transplantation for children and adolescents with aplastic anaemia or myelodysplasia. Br J Haematol 1997: 96: 749-756.
5. HOWS JM, YIN JL, MARSH J, et al. Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia. Blood 1986: 68: 1322-1328.
6. CAMITTA B, ASH R, MENITOVE J, et al. Bone marrow transplantation for children with severe aplastic anemia: Use of donors other than HLA-identical siblings. Blood 1989: 74: 1852-1857.
7. CHAMPLIN RE, HOROWITZ MM, VAN BEKKUM DW, et al. Graft failure following bone marrow transplantation for severe aplastic anemia: Risk factors and treatment results. Blood 1989: 73: 606-613.
8. KOJIMA S, MATSUYAMA T, KATO S, et al. Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: The Japan Marrow Donor Program. Blood 2002: 100: 799-803.
9. DEEG HJ, SEIDEL K, CASPER J, et al. Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy. Biol Blood Marrow Transplant 1999: 54: 243-252.
10. PETERSDRF EW, GOOLEY TA, ANASETTI C, et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 1998: 92: 3515-3520.
11. KOJIMA S, INABA J, YOSHIMI A, et al. Unrelated donor marrow transplantation in children with severe aplastic anaemia using cyclophosphamide, anti-thymocyte globulin and total body irradiation. Br J Haematol 2001: 114: 706-711.
12. VASSILIOU GS, WEBB DK, PAMPHILON D, KNAPPER S, VEYS PA. Improved outcome of alternative donor bone marrow transplantation in children with severe aplastic anemia using a conditioning regimen containing low-dose total body irradiation, cyclophosphamide and Campath. Br J Haematol 2001: 114: 701-705.
13. CRAWFORD SW, LONGTON G, STORB R. Acute graft-versus-host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia. Bone Marrow Transplant 1993: 12: 225-231.
14. CLEMENT-DE BOERS A, OOSTDIIK W, VAN WEEL-SIPMAN MH, et al. Final height and hormonal function after bone marrow transplantation in children. J Pediatr 1996: 129: 544-550.
15. DEEG HJ, LEISENRING W, STORB R, et al. Long-term outcome after marrow transplantation for severe aplastic anemia. Blood 1998: 91: 3637-3645.
16. CURTIS RE, ROWLINGS PA, DEEG HJ, et al. Solid cancers after bone marrow transplantation. N Engl J Med 1997: 336: 897-904.
17. PIERGA JY, SOCIE G, GLUCKMAN E, et al. Secondary solid malignant tumors occurring after bone marrow transplantation for severe aplastic anemia given thoraco-abdominal irradiation. Radiother Oncol 1994: 30: 55-58.
18. SOCIE G, HENRY-AMAR M, BACIGALUPO A, et al. Malignant tumors occurring after treatment of aplastic anemia. N Engl J Med 1993: 329: 1152-1157.
19. DEEG HJ, SOCIE G, SCHOCH M, et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: A joint Seattle and Paris analysis of results in 700 patients. Blood 1996: 87: 386-392.
20. THOMAS ED, STORB R, FEFER A, et al. Aplastic anemia treated by marrow transplantation. Lancet 1972: 1: 284-289.
21. STORB R, THOMAS ED, WEIDEN PL, et al. Aplastic anemia treated by allogeneic bone marrow transplantation: A report of 49 new cases from Seattle. Blood 1976: 48: 817-841.
22. STORB R, RUDOLPH RH, GRAHAM TC, THOMAS ED. The influence of transfusions from unrelated donors upon marrow grafts between histocompatible canine siblings. J Immunol 1971: 107: 409-413.
23. STORB R, THOMAS ED, BUCKNER CD, et al. Marrow transplantation in thirty "untransfused" with severe aplastic anemia. Ann Intern Med 1980: 92: 30-36.
24. STORB R, ETZIONI R, ANASETTI C, et al. Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood 1994: 84: 941-949.
25. PARKMAN R, RAPPEPORT J, CAMITTA B, LEVEY RH, NATHAN DG. Successful use of multiagent immunosuppression in the bone marrow transplantation of sensitized patients. Blood 1978: 52: 1163-1169.
26. RAMSAY NK, KIM T, NESBIT ME, et al. Total lymphoid irradiation and cyclophosphamide as preparation for bone marrow transplantation for severe aplastic anemia. Blood 1980: 55: 344-346.
27. FEIG SA, CHAMPLIN R, ARENSON E, et al. Improved survival following bone marrow transplantation for aplastic anemia. Br J Haematol 1983: 54: 509-517.
28. GALE RP, HO W, FEIG S, et al. Prevention of graft rejection following bone marrow transplantation. Blood 1981: 57: 9-12.
29. STORB R, PRENTICE RL, THOMAS ED. Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. N Engl J Med 1977: 296: 61-66.
30. STORB R, DONEY KC, THOMAS ED, et al. Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. Blood 1982: 59: 236-246.
31. STORB R, BLUME KG, O'DONNELL MR, et al. Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: The experience in four centers. Biol Blood Marrow Transplant 2001: 7: 39-44.
32. DEEG HJ, ANASETTI C, PETERSDORF E, et al. Cyclophosphamide plus ATG conditioning is insufficient for sustained hematopoietic reconstitution in patients with severe aplastic anemia transplanted with marrow from HLA-A,B,DRB matched unrelated donors. Blood 1994: 83: 3417-3418
33. WAGNER JL, DEEG HJ, SEIDEL K, et al. Bone marrow transplantation for severe aplastic anemia from genotypically HLA-nonidentical relatives. An update of the Seattle experience. Transplantation 1996: 61: 54-61.
34. APPELBAUM FR. The influence of total dose, fractionation, dose rate and distribution of total body irradiation on bone marrow transplantation. Semin Oncol 1993: 20: 3-10.
35. DEEG HJ, AMYLON MD, HARRIS RE, et al. Marrow transplants from unrelated donors for patients with aplastic anemia: Minimum effective dose of total body irradiation. Biol Blood Marrow Transplant 2001: 7: 208-215.
36. DEEG HJ, O'DONNELL M, TOLAR J, et al. Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood 2006: 108: 1485-1491.
37. BACIGALUPO A, LOCATELLI F, LANINO E, et al. Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: A report from the EBMT-SAA Working Party. Bone Marrow Transplant 2005: 36: 947-950.
38. MARGOLIS D, CAMITTA B, PIETRYGA D, et al. Unrelated donor bone marrow transplantation to treat severe aplastic anaemia in children and young adults. Br J Haematol 1996: 94: 65-72.
39. LEE JH, CHOI SJ, LEE JH, et al. Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia. Bone Marrow Transplant 2005: 35: 755-761.
40. KANG HJ, SHIN HY, CHOI HS, AHN HS. Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia. Bone Marrow Transplant 2004: 34: 939-943.
41. GUPTA V, BALL SE, SAGE D, et al. Marrow transplants from matched unrelated donors for aplastic anemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning. Bone Marrow Transplant 2005: 35: 467-471.
42. ANASETTI C, PETERSDORF EW, MARTIN PJ, WOOLFREY A, HANSEN JA. Improving availability and safety of unrelated donor transplants. Curr Opin Oncol 2000: 12: 121-126.
43. SANDERS JE, HAWLEY J, LEVY W, et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996: 87: 3045-3052.
44. JACOB A, BARKER H, GOODMAN A, HOLMES J. Recovery of spermatogenesis following bone marrow transplantation. Bone Marrow Transplant 1998: 22: 277-279.
45. JACOB A, GOODMAN A, HOLMES J. Fertility after bone marrow transplantation following conditioning with cyclophosphamide and total body irradiation. Bone Marrow Transplant 1995: 15: 483-484.
46. MATSUMOTO M, SHINOHARA O, ISHIGURO H, et al. Ovarian function after bone marrow transplantation performed before menarche. Arch Dis Child 1999: 80: 452-454.